Cellectar Biosciences CLRB
NASDAQ CLRB
$1.21 -0.07 (-5.47%)
As of: Oct 22, 2026 · 10:49 AM EDT

Cellectar Biosciences (CLRB) EBIT Margin (2012 - 2026)

Updated

Analysis

Cellectar Biosciences (CLRB) EBIT Margin (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,167.56 Bn 1,136.14 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 635.76 Bn 554.29 Bn 17.26 Bn 28.21%
3 AbbVie 503.27 Bn 476.38 Bn 12.70 Bn 37.86%
4 Merck 377.51 Bn 331.89 Bn 12.21 Bn -3.52%
5 Novartis Ag 304.07 Bn 268.06 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.53 Bn 241.22 Bn 12.86 Bn 20.57%
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.26 Bn 168.46 Bn 6.22 Bn -133.21%
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn 28.37%
10 Cellectar Biosciences 14.80 Mn -55.98 Mn - -5,395.97%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5,395.97%
Dec 31, 2025 -5,832.06%
Sep 30, 2025 -4,310.08%
Jun 30, 2025 -6,859.27%
Mar 31, 2025 -4,673.55%
Dec 31, 2024 -5,218.80%
Sep 30, 2024 -4,192.58%
Jun 30, 2024 -4,166.44%
Mar 31, 2024 -3,752.23%
Dec 31, 2023 -9,012.86%
Sep 30, 2023 -18,418.04%
Jun 30, 2023 -11,395.99%
Mar 31, 2023 -7,018.48%
Dec 31, 2022 -5,034.14%
Sep 30, 2022 -187,691.79%
Jun 30, 2022 -1,545,846.99%
Mar 31, 2022 -1,427,959.77%
Sep 30, 2021 -986,382.03%
Jun 30, 2021 -914,823.82%
Mar 31, 2021 -269,243.52%
API Access

Cellectar Biosciences EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=CLRB&period=max&api_key=YOUR_API_KEY